Guest guest Posted December 1, 1999 Report Share Posted December 1, 1999 > Dr. Mazlen > Today we have a very important show from both the medical and research > standpoints, this is a highlight. We're going to be talking live in just a > minute with Dr. Garth L. Nicolson, Chief Scientific Officer and Research > Professor, Professor of Internal Medicine and Chief of the Institute for > Molecular Medicine which is in Huntington Beach, California. With no > reservation, Dr. Nicolson, in my opinion, is one of the foremost authorities in > the world on the mycoplasmas and related infections. Welcome to our show, Dr. > Nicolson. > Prof. Nicolson > Thanks for having me on board. > > Dr. Mazlen > We're delighted to have you on board. It's an exciting thing for us because a > lot of people's health and lives may hang in the balance on the work that > you're doing and publishing. Could you tell our listening audience some of the > advances in this area of mycoplasma disease causation, since you were a guest > in the year? > > Prof. Nicolson > Well, I think what we've done in the intervening period of time is that we've > really nailed down the fact that chronic infections are a very important aspect > of a variety of different chronic illnesses, from rheumatoid arthritis, chronic > fatigue syndrome, fibromyalgia syndrome, inflammatory bowel disease, a lot of > respiratory diseases, chronic asthma, and so on and not only mycoplasma but a > variety of other chronic infections as well and people, I think, in the past > did not realize the extent, or the involvement of these types of infections in > these chronic disorders and the fact that these disorders can be either > causative or they can a cofactor in the disease, that is be an important > element in the disease or it can even be operative if the infections after the > disease are triggered by something else and they're involved in the progression > of the disease and making it worse. > > Dr. Mazlen > How many years can you have a mycoplasma infection without being aware of it by > a diagnostic procedure? > > Prof. Nicolson > Well, it's not really well known. We do know, for example, from the Gulf War > that it took some patients as long as three years before they started > exhibiting signs and symptoms of infection that we felt occur in 1991 and their > family members, when they came down there was often a delay anywhere from 6 > months to 2 years before they showed signs and symptoms. So, there's a > significant delay. > > Dr. Mazlen > How long can it stay in your body if you don't treat it? > > Prof. Nicolson > Well, we don't know. This is one of the important questions to which we'd like > the answer. We do know that some people in the general population will test > positive, a few percent, for example, and we don't know if these are people > that will ultimately become sick because of the long latency of this type of > infection or whether they're just carriers. > > Dr. Mazlen > Of course, and you make the point, in many of your papers that this is a slow > growing organism. > > Prof. Nicolson > It's very slow growing and I think that's why these problems show up only after > a very long latency period. > > Dr. Mazlen > Now, you mentioned in the letter that you wrote to me recently, that you've > learned that as of 1994 over 6,000 U.S. soldiers have died of infectious, > chemical exposures and other causes from operation Desert Storm and that the > numbers are much higher. What's going on there in your opinion? > > Prof. Nicolson > Well we don't know the actual numbers, because the actual numbers are > classified. We've heard everything from 15,000 to more than 20,000 of our > veterans have died of a variety of different illnesses including these very > unusual chronic infections that can progress. > > Dr. Mazlen > And, of course, I want to congratulate you on your efforts to bring this to the > attention of Congress where you have testified. Now, you mention also that > there is a study ongoing, a multi-center clinical trial based on your work on > treatment with the VA. What's that about? > > Prof. Nicolson > Well, that 6 million dollar trial is really to diagnose and treat Gulf War > Veterans who have mycoplasma illnesses and it's taking place at over 30 VA and > DoD institutions around the country and we hope within a year, a year and a > half that we'll get information about the antibiotic treatment that we've, of > course, developed to treat these types of infections. > > Dr. Mazlen > We're going to get back to that in a few minutes, but maybe you could just tell > us very briefly... you mentioned that you're now using a forensic PCR or > polymerase chain reaction technique for diagnosing this disease and I know it's > going to be available because you're opening up a new center, you have a new > international diagnostic lab which is now open. What does this forensic PCR > test mean? > > Prof. Nicolson > Well the forensic PCR test is simply using some of the tools of forensic > pathology where you can isolate very small amounts of blood, blood cells like > white blood cells that have DNA and then couple that with an amplification > technique, polymerase chain reaction, you have a very sensitive tool to find > these infections inside the blood of a patient, and up until just a few years > ago when we first started using this it was very difficult to find these types > of infections and that's why you didn't hear very much about it. > > Dr. Mazlen > Well, I've noticed that already in my practice, because I've been applying the > variety of tests to patients based on your early work, I've been finding that > the standard antibody testing which is typical IgG and IgM for mycoplasma > pneumoniae, for example, is not at all a valid test compared to PCR. Just how > bad is it in terms of making the diagnosis? How inaccurate? > > Prof. Nicolson > Well, I think it's very inaccurate and the reason for that is that these > infections are intracellular, that is, they get inside the cells in your > tissues and because they reside inside the cells they don't stimulate much of > an immune response. There's been some very interesting animal studies that were > published by the army, the Armed Forces Institute of Pathology, that shows that > if you take these types of infectious agents like mycoplasma fermentans and > inject them into monkeys, they don't show any antibody response until years > later and only a few months before they die. So these can cause a fatal > progressive disease, so they can be dangerous and antibodies won't really pick > this up until a person has very well progressed in the disease process. > > Dr. Mazlen > Well that, of course, is alarming and it also points out the opportunity to use > the new testing in order to be able to offer therapy to patients early before > this type of progression and for that, we thank you for bringing that to the > attention of the medical community at large and to Congress as well. Now, what > about Chronic Fatigue Syndrome, what's happening with the patients there who > might have mycoplasma infections? > > Prof. Nicolson > We're finding about 60% of these patients do have these types of infections and > we're also looking at other types of chronic infections like chlamydial > infections. There are a very high percentage that have those. And we just have > a study coming out in a European microbiology journal showing that with time, > Chronic Fatigue Syndrome patients tend to collect these infections and so > patients who've been sick a decade or more tend to have multiple infections and > they also tend to have worsening signs and symptoms, that is patients that have > the multiple infections, there signs and symptoms slowly become worse, so we > can actually tag the number of infectious agents, the number of different > types, the severity of the disease and also the length of the disease process. > So this explains why so few patients with Chronic Fatigue Syndrome ever recover > from their illness. With time their immune systems are compromised, they can > collect these opportunistic infections and they will make them worse or keep > them just as sick as they were before and they can't seem to recover. > > Dr. Mazlen > That's certainly true from what I've seen over 20 years. In addition to that I > have patients that you've diagnosed with your laboratory testing who have > multiple infections of mycoplasma and the ones with m.hominus, in particular, > are pretty sick and they have that in combination with others which you mention > in your paper and the paper entitled " Multiple Mycoplasma Infections Detected > in Blood of Chronic Fatigue Syndrome and Fibromyalgia Syndrome Patients " and > that's in the European Journal of Clinical Microbiology and Infectious > Diseases. I'll give you the number where you can reach the Institute for > Molecular Medicine and, of course, Dr. Nicolson which is 714-903-2900. Also you > may fax your messages to them at 714-379-2082. Garth, tell me about some > progress in the area of treatment. What have you been seeing and what are you > recommending. I know that doxycycline is one of the staples, but what else are > you using. > > Prof. Nicolson > Actually, we're using several different antibiotics, sometimes these have to be > cycled in. And in some patients that are really severely sick we often have to > combine different antibiotics. I'll be glad to send people information on that > if they write to me at the Institute for Molecular Medicine or they could go to > our website at www.immed.org and find information about treatment, but the > antibiotics I think are very useful in suppressing the infections but as you > know, this is not the whole story, most people that have these infections have > compromised immune systems and so we have to worry about building them back up. > Proper nutrition is very important, proper vitamins and minerals are important. > A lot of these patients have poor absorptions so they're not getting the proper > B vitamins and other essential materials that they need to overcome these > illnesses so we have to attend to a lot of different problems with these > people, not just a matter of suppressing the infection. > > Dr. Mazlen > Also, one interesting thing, because we know that these patients tend to have > relapses when there's low oxygen tension like in air travel, for example, which > you pointed out in an earlier show, and we're going to get back to that in > terms of treatment with hyperbaric oxygenation in a minute, but what does the > mycoplasma do to the oxygen delivery system in the blood? > > Prof. Nicolson > Well, we're not exactly sure what the mycoplasma does to that in these patients > but we do know that it does infect the endothelium, the cell lining the > vascular systems and causes changes, we think, possibly in the exchange of > oxygen in the tissues. We do know that higher oxygen will suppress these types > of infections because basically they're what you call borderline anerobic > infections, so we know that the people that take long flights often in > pressurized aircrafts at high altitudes, often have relapses after they land if > they have Chronic Fatigue Syndrome or fibromyalgia or other chronic illnesses. > We often see this is air crews and airline pilots and we're working with a > number airline pilots on this. We just established near our institute a > hyperbaric center, it's called Molecular Hyperbaric Medicine and this is headed > by Dr. Irwin, he's actually the son of the former Deputy Surgeon General > of the Navy and he's very interested in hyperbaric medicine, so we'll be > offering that to patients along with some of the other therapies that we've > been trying to develop to treat these chronic illnesses. > > Dr. Mazlen > So you see that as an adjunctive therapy along with antibiotics. > > Prof. Nicolson > Yes, we do, and particularly people that have acute episodes, I think it's > quite useful. It's not in itself going to help people overcome these types of > infections, because the generally high oxygen will suppress these infections > but will not eliminate them. It will suppress the growth of them and some of > the signs and symptoms will be temporarily alleviated but they eventually come > back again, so we have to really get at these infections and that just requires > long term antibiotics and nutritional support. > > Dr. Mazlen > OK. That's all very important and people can write to you for that information. > I have an important question to ask you. It's a leading question. You may not > be able to answer it. But can these chronic mycoplasma infections, in some way, > maybe not yet known, contribute to the causation of cancer? > > Prof. Nicolson > Well, this is a hot topic right now because we know that these microorganisms > give off genotoxic substances, that is substances that can modify our genes and > actually mutate them. Some of these are activated oxygen species that will > attack DNA. We do know that if you take these types of mycoplasmas that we > found in patients and put them into cell cultures that they will result in > spontaneous transformation of those cells eventually and lower their threshold > to chemicals thousands of fold, so in effect, what they may be doing is > lowering the threshhold of carcinogenesis. You if you have these infections, it > might make you more prone to have cancer. We just don't know, there's not > enough information on this right now, but it's certainly a troubling sign. > > Dr. Mazlen > Well, that's exactly why I asked you and I appreciate your candid answer about > it. What about the actual damage to chromosones themselves because some people > have reported, and this is Urnovitz's work with others, that there's been > nucleic acid or pieces resulting from chromosomal damage found in Gulf War > patients. What about that? > > Prof. Nicolson > Right now we don't know if the damage that they're looking at is the damage > caused by mycoplasmas or not because they only find it in one half of the > specimens that they look at that's about the same percentage that we find are > infected with mycoplasma and we know that the mycoplasma gives out substances > which can cause the same kind of chromosome damage that they're looking at. The > chromosome damage is not a new thing. This has been seen for years. In fact, > there's about a 20 year literature history on this, and what's been found is > even if you look at smokers compared to non-smokers, there's an increase in > chromosome fragility or chromosome damage, so this is something that you see > quite often in people that have been exposed to toxic materials of any type, be > it biological or chemical or radiological. > > Dr. Mazlen > OK, now that's fair and that's certainly in the literature. There's no question > about the fact that that's been shown. What about, however, the possible > connection from this genotoxic stuff that's put out by mycoplasma and the birth > defects noted in the children of the Gulf War veterans? > > Prof. Nicolson > Well, again, we just don't know. There's just not enough research on this to > know whether this contributed to, in fact, the birth defects that are found in > Gulf War famililes, particularly in their offspring, or whether that was caused > primarily by chemicals or both. It's just a very very difficult area to work in > because of the multiple toxic exposures that occurred during the Gulf War. > > Dr. Mazlen > Well, of course, I knew it was a difficult question. But I wanted to ask you > because we needed to get even your theoretical thinking about it and how other > people start looking at it and thinking about it also and for that I appreciate > even mentioning even a tentative possibility of it's connection because it > needs to be explored. Garth, I have a question for you about the mycoplasma's > effect on the host immune system. You've had papers published on this and you > call it a stealth type of response. Talk to the audience about this mycoplasma > stealth activity is. > > Prof. Nicolson > Well, these types of microorganisms, as I mentioned, penetrate into cells and > tissues and they can virtually go into any organ or tissue in the body. We find > some patients, for example, that have coronary problems because of these > infections. My own father has this, by the way, when he had a mycoplasma > pneumoniae infection and he had endocarditis, and was really headed for a major > heart attack. We were able to diagnose it and turn that around and now he's > made a full recovery. We just don't know how many people are in this situation > that might have liver failure, lung problems with chronic pneumonia, heart > problems, coronary problems, renal problems, problems with their kidneys > because of infections. These types of infections are insidious because when > they hide inside the cells they can really escape from the immune system, but > these types of infections also have another property that also helps them > escape from the immune system and that is that they can suppress the immune > system. They can actually attack the immune system, just like they attack other > cells in our body, and this ends up in some cases resulting in a suppression of > immunity in general. And so we can have patients whose immune systems are > compromised and this leaves them wide open to a variety of other opportunistic > infections. And these patients, which are the worst, I think, to deal with, > they have a variety of different infections. They yeast infections, they have > other bacterial infections, viruses, and so on and it's extremely difficult > dealing with these patients, because building back their immune systems is very > very difficult. > > Dr. Mazlen > I certainly can second that because I've seen that, and I'm dealing with it > currently in my practice. And I want to say that Dr. Nicolson has helped me > greatly by his work and by his advice over time and he has protocols which you > can also get for your treating physicians and healthcare personnel. Once again > his phone number at the Institute for Molecular Medicine is 714-903-2900 and > can you give your website again? > > Prof. Nicolson > Yes, it's www.immed.org. If you remember " immediately " you can remember the > website. > > Dr. Mazlen > I think, Garth, and I'm extending an information to you to come to New York and > we'll organize a symposium on mycoplasma illnesses. I want to help put it > together with you so, let's work on that or something like it in the future > because your work is just extremely important. A lot of people's health is > slipping by the boards, or as they say, slipping through the cracks, so to > speak, and they're not being treated adequately and not enough serious > attention is being paid to these problems. I've actually had infectious disease > specialists call me to ask me about things like this looking for advise with > Chronic Fatigue Syndrome, for example, in terms of what type of multiple > infections may be present and this really is pandora's box. Almost anything is > possible, as you pointed out. And as you mentioned about your father with the > infected endocarditis, people could even go on to die, I've seen it happen. We > can't work fast enough or do too much in this area. I urge you to support the > Institute for Molecular Medicine. This is my personal appeal to you and I want > to say that we're delighted. We're going to want to have you back again but > we're going to want to do some other things to get this information out and > we're going to try to work it out in the future. How contagious is it, Garth? > > Prof. Nicolson > Well, it's only moderately contagious. It does seem to require some time to > pass it. The most at risk are immediate family members because they make the > closest contact with an individual who is sick. > > Dr. Mazlen > What about children? > > Prof. Nicolson > Well, children can pick this up. We have a lot of family members who have > gotten sick because of it. Children's immune systems are a little bit stronger > and some of them are able to withstand it, but we have a lot of children in > Gulf War Illness families who are sick because of this. > > Transcribed by > > Carolyn Viviani > carolynv@... > > Permission is given to repost, copy and distribute this transcript as long as > my name is not removed from it. > > © 1999 G. Mazlen, M.D. > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.